• SENSEX 81,332.31
    184.09 (+0.23%)
  • BANKNIFTY 54,940.85
    -442.00 (--0.80%)
  • Cochin Shipyard
    1,797.10 2,977.10(%)
  • Swiggy
    304.35 297.00(%)
  • Garden Reach Sh.
    2,264.65 2,834.60(%)
  • Mazagon Dock
    3,229.00 3,170.00(%)
  • M & M
    3,100.00 3,276.30(%)
  • Tata Motors
    686.00 542.55(%)
  • Bharat Dynamics
    1,821.95 1,794.70(%)
  • Bharat Electron
    345.90 340.35(%)
  • Godrej Propert.
    2,125.00 3,400.00(%)
  • Hind.Aeronautics
    4,757.45 5,675.00(%)
  • Suzlon Energy
    60.30 86.04(%)
  • Tube Investments
    3,049.30 4,807.05(%)
  • Tata Steel
    157.15 184.60(%)
  • St Bk of India
    798.50 679.65(%)
  • Waaree Energies
    2,873.05 3,740.75(%)
  • Yes Bank
    21.32 27.41(%)
  • Bharti Airtel
    1,870.00 1,916.90(%)
  • One 97
    829.15 331.45(%)
  • V-Mart Retail
    3,522.45 2,058.70(%)
  • Reliance Power
    44.60 54.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Advanced Enzyme Technologies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19816.0
  • ISIN : INE837H01020
288.85 -8 (-2.60%)
  • As on 14 May 2025 (EOD)

  • Today’s Low

    286.20

  • Today’s High

    306.85

  • Open

    298.75

  • Perv Close

    296.55

  • 52W Low

    257.90

  • 52W High

    571.00

Key Indicators

  • P/E(TTM)

    30.50

  • Mar.Cap (₹Cr.)

    3,231.69

  • Div & Yield %

    1.80

  • Book Value(₹)

    53.82

  • Debt-Equity Ratio

    -2.60

  • AGM Date

    13-May-2025

  • EPS

    9.47

  • P/E Ratio

    30.50

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    3,231.69

  • RONW (%)

    10.70

  • ROCE (%)

    14.53

Score Board

  • Equity (₹ in Cr.)

    22.38

  • BV (₹)

    56.30

  • Sales( ₹ in Cr.)

    351.41

  • NP (in Cr.)

    102.42

  • NP Var(%)

    -17.0

  • Div%

    260.0

  • CPS (₹)

    10.20

  • EPS (₹)

    9.20

  • Traded Value (₹ in Lakhs)

    3,231.13

  • 52 Week High

    571.00

  • 52 Week Low

    257.90

  • Price BSE

    289.0

  • Price NSE

    289.00

  • Market Capital( in Cr.)

    3,231.13

  • P/C Ratio

    28.40

  • P/E Ratio

    31.60

  • Price Vs.BV

    9.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 365.47 311.53 272.80 283.47 247.35 222.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 365.47 311.53 272.80 283.47 247.35 222.09
Other Income 58.81 9.81 9.08 6.82 9.00 5.61
Stock Adjustments 7.83 -1.48 13.52 -1.27 5.68 -5.40
Total Income 432.11 319.86 295.40 289.02 262.03 222.30
EXPENDITURE :            
Raw Materials 139.56 121.43 112.72 95.03 94.44 80.43
Power and Fuel Cost 22.73 19.58 16.19 11.53 10.95 10.21
Employee Cost 49.97 41.42 39.32 34.23 32.61 35.07
Other Manufacturing Expenses 18.57 14.52 13.53 9.25 9.08 7.36
Selling and Administration Expenses 33.05 32.37 28.66 28.49 25.74 27.93
Miscellaneous Expenses 22.95 5.64 3.08 2.81 3.26 2.80
Employee Benefit Expenses 49.97 41.42 39.32 34.23 32.61 35.07
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 286.83 234.97 213.49 181.35 176.08 163.81
Operating Profit 145.28 84.89 81.90 107.67 85.96 58.49
Interest 0.39 0.33 0.27 0.24 1.29 2.72
Gross Profit 144.89 84.56 81.63 107.43 84.67 55.77
Depreciation 10.90 10.28 9.56 9.01 8.81 8.56
Profit Before Tax 133.99 74.28 72.07 98.42 75.86 47.21
Current Tax 26.95 18.25 18.02 24.84 19.39 11.96
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.08 0.50 -0.46 2.57 -1.49 0.01
Reported Net Profit 108.12 55.53 54.51 71.01 57.96 35.23
Extraordinary Items -15.13 -0.59 0.89 0.51 0.00 -0.05
Adjusted Net Profit 123.25 56.12 53.62 70.50 57.96 35.28
Adjustment below Net Profit -0.10 0.49 0.02 -0.03 -1.31 -0.61
P & L Balance brought forward 417.50 372.66 328.19 263.91 213.96 184.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 55.91 11.18 10.06 6.70 6.70 5.58
P & L Balance carried down 469.61 417.50 372.66 328.19 263.91 213.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 255.00 50.00 50.00 45.00 30.00 30.00
Dividend Per Share(Rs) 5.10 1.00 1.00 0.90 0.60 0.60
Earnings Per Share-Unit Curr 9.67 4.97 4.88 6.36 5.19 3.16
Earnings Per Share(Adj)-Unit Curr 9.67 4.97 4.88 6.36 5.19 3.16
Book Value 51.91 46.98 42.97 38.97 33.17 28.61
Book Value(Adj)-Unit Curr 51.91 46.98 42.97 38.97 33.17 28.61

Shareholding Pattern

  • Promoter Group

    43.08%

  • Public Share Holding

    56.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 45,990,885 45,990,885.00 45,990,885 45,990,885
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 45,990,885 41.11 45,990,885 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,209,100 1.97 2,209,100 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,209,100 1.97 2,209,100 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 13,310,458 11.90 13,310,458 70
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 5,991,978 5.36 5,991,978 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,170,772 2.83 3,170,772 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 22,473,208 20.09 22,473,208 84
2] Non Institution
Bodies Corporate 1,439,650 1.29 1,439,650 342
Clearing Members 591 0.00 591 3
Directors of their Relatives 1,899,750 1.70 1,899,750 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,760,772 3.36 3,760,772 1,675
Foreign Non Institution Other 13,509,522 12.07 13,509,522 1
Hindu Undivided Families 599,888 0.54 599,888 1,448
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,405,100 1.26 1,405,100 6
Individuals holding nominal share capital up to Rs. 1 lakh 17,253,070 15.42 17,040,070 61,731
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 552,701 0.49 552,701 2
Others 763,413 0.68 763,413 13
Sub Total 41,207,957 36.83 40,994,957 65,224
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 111,881,150 100.00 111,668,150 65,322

Company Background

Advanced Enzyme Technologies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Advanced Enzyme Technologies Ltd
  • BSE Code : 19816.0
  • ISIN : INE837H01020

  • Incorporation Year

    1989

  • Registered Office

    Sun Magnetica 5th Floor
    Nr LIC Serivce Road Louiswadi, Thane,
    Maharashtra-400604

  • Telephone

    91-22-41703200

  • FAX

    91-22-25835159

  • Chairman

    VASANT RATHI

  • Managing Director

  • Company Secretary

    Sanjay Basantani

  • Auditor

    MSKA & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Advanced Enzyme Technologies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Advanced Enzyme 288.80 424.28 365.47 34.18 27.61
Abbott India 30,424.00 6,097.18 5,848.91 48.45 44.71
Astrazeneca Phar 8,183.35 1,330.33 1,295.53 210.97 33.26
P & G Health Ltd 5,088.90 1,166.89 1,151.26 35.71 39.76
Glaxosmi. Pharma 2,790.15 3,530.73 3,407.25 55.48 44.44
Cipla 1,519.45 17,645.00 16,574.34 26.05 20.10
Amrutanjan Healt 709.90 437.58 421.23 41.61 20.84
Guj. Themis Bio. 306.75 174.19 169.82 63.51 44.82
Fermenta Biotec. 266.40 315.24 307.09 25.25 4.10
Bliss GVS Pharma 118.70 638.96 605.46 27.16 11.19
Ambalal Sarabhai 37.02 11.70 3.81 15.82 1.92